市场调查报告书
商品编码
1597128
欧洲血气和电解质分析仪市场预测至 2031 年 - 区域分析 - 按产品和最终用户Europe Blood Gas and Electrolyte Analyzer Market Forecast to 2031 - Regional Analysis - by Product and End User |
2023年欧洲血气和电解质分析仪市值为7.0268亿美元,预计2031年将达到10.7496亿美元;预计2023年至2031年复合年增长率为5.5%。
床边诊断的日益普及推动了欧洲血气和电解质分析仪市场
现场护理测试可在患者所在地或附近提供即时诊断结果,从而实现快速临床决策、简化工作流程并提高患者治疗效果。对及时介入、高效诊断流程和个人化医疗保健服务的需求推动了对分散测试解决方案的需求。血液气体和电解质分析仪使医疗保健提供者能够在患者床边、急诊室或远端环境中执行关键的诊断测试,从而促进对血液气体参数、电解质水平和酸碱状态的现场评估。床边分析仪的可及性和即时性使临床医生能够及时启动适当的治疗,即时监测患者的反应,并优化急诊护理场景中的临床决策。
向现场诊断的转变推动了血液气体和电解质分析仪的技术进步,重点关注紧凑、自动化且易于使用的设备,以提供准确、快速的结果。这些分析仪利用先进技术提供精确的测量、品质保证功能以及资料管理和与电子健康记录整合的连接选项。将护理点分析仪无缝整合到医疗保健工作流程中可以提高营运效率,缩短结果週转时间,并提高患者护理的整体品质。此整合彻底改变了诊断过程,使医疗保健提供者能够获得即时资料洞察,并实现及时干预,从而增强患者管理和临床决策。因此,随着医疗机构接受现场检测的优势,对便携式和用户友好型血气和电解质分析仪的需求正在上升。
欧洲血气和电解质分析仪市场概况
欧洲血气和电解质分析仪市场包括法国、德国、英国、义大利、西班牙和欧洲其他地区的综合市场。欧洲在全球血气和电解质分析仪市场中占有重要地位,预计在预测期内将出现强劲成长。市场成长归因于慢性病发病率的上升以及各种临床应用越来越多地采用血气和电解质分析仪,预计这将推动市场成长。
欧洲血气及电解质分析仪市场收入及 2031 年预测(百万美元)
欧洲血气和电解质分析仪市场细分
欧洲血气和电解质分析仪市场按产品、最终用户和国家分类。
依产品,欧洲血气电解质分析仪市场分为血液气体分析仪、电解质分析仪、组合分析仪等。组合分析仪细分市场在 2023 年占据最大的市场份额。
按最终用户划分,欧洲血气和电解质分析仪市场分为医院和诊所、临床和诊断实验室、家庭护理等。 2023 年,临床和诊断实验室领域占据最大的市场份额。
依国家/地区划分,欧洲血气和电解质分析仪市场分为德国、英国、法国、西班牙、义大利和欧洲其他地区。 2023年,德国在欧洲血气和电解质分析仪市场份额中占据主导地位。
Abbott Laboratories、Dalko Diagnostics Private Limited、Erba Diagnostics Mannheim GmbH、Hoffmann-La Roche Ltd、Medica Corporation、Nova Biomedical Corporation、Siemens Healthineers AG、Werfen SA、Radiometer Medical ApS 和 Sensa Core Medical Instrumentation Pvt Ltd. 是一些领先的公司在欧洲血气和电解质分析仪市场运作。
The Europe blood gas and electrolyte analyzer market was valued at US$ 702.68 million in 2023 and is projected to reach US$ 1,074.96 million by 2031; it is estimated to record a CAGR of 5.5% from 2023 to 2031.
Rising Adoption of Point-of-Care Diagnostics Drives Europe Blood Gas and Electrolyte Analyzer Market
Point-of-care testing offers immediate diagnostic results at or near the patient's location, enabling rapid clinical decision-making, streamlined workflows, and enhanced patient outcomes. The need for timely interventions, efficient diagnostic processes, and personalized healthcare delivery fuels the demand for decentralized testing solutions. Blood gas and electrolyte analyzers allow healthcare providers to perform critical diagnostic tests at the patient's bedside, in the emergency department or in remote settings, facilitating on-the-spot assessment of blood gas parameters, electrolyte levels, and acid-base status. The accessibility and immediacy of point-of-care analyzers empower clinicians to initiate appropriate treatments promptly, monitor patient responses in real time, and optimize clinical decision-making in acute care scenarios.
The shift toward point-of-care diagnostics drives technological advancements in blood gas and electrolyte analyzers, focusing on compact, automated, and easy-to-use devices that deliver accurate and fast results. The analyzers leverage advanced technologies to provide precise measurements, quality assurance features, and connectivity options for data management and integration with electronic health records. The seamless integration of point-of-care analyzers into healthcare workflows enhances operational efficiency, reduces turnaround times for results, and improves the overall quality of patient care. The integration revolutionizes the diagnostic process, empowering healthcare providers with immediate data insights and enabling timely interventions that enhance patient management and clinical decision-making. Thus, as healthcare settings embrace the advantages of point-of-care testing, the demand for portable and user-friendly blood gas and electrolyte analyzers is rising.
Europe Blood Gas and Electrolyte Analyzer Market Overview
The Europe blood gas and electrolyte analyzer market includes the consolidated markets for France, Germany, the UK, Italy, Spain, and the Rest of Europe. Europe holds a significant position in the global blood gas and electrolyte analyzer market and is expected to record a vigorous growth rate during the forecast period. The market growth is attributed to the rising incidences of chronic diseases and increased adoption of blood gas and electrolyte analyzers for various clinical applications, which is expected to drive the market growth.
Europe Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)
Europe Blood Gas and Electrolyte Analyzer Market Segmentation
The Europe blood gas and electrolyte analyzer market is categorized into product, end user, and country.
Based on product, the Europe blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.
By end user, the Europe blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.
By country, the Europe blood gas and electrolyte analyzer market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe blood gas and electrolyte analyzer market share in 2023.
Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the Europe blood gas and electrolyte analyzer market.